Ambac Financial Group has officially rebranded as Octave Specialty Group, marking its transformation into a dedicated ...

Octave Specialty Group's consensus analyst price target has recently increased from $14.67 to $16.33. This move is driven by higher expectations for the company. The upward revision is largely ...

Ambac Financial Group (($AMBC)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Octave ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, a leading precision care company focused on delivering a new standard of care for multiple sclerosis (MS) and other neurodegenerative diseases ...

Ambac Financial Group, Inc. (NYSE: AMBC) today announces it has rebranded to Octave Specialty Group, Inc. ("Octave"), marking ...

Ambac Financial (AMBC) announced it has rebranded to Octave Specialty Group. The company will begin trading under its new ticker symbol (OSG) on ...